These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17288980)

  • 1. A fluorescence-resonance-energy-transfer-based protease activity assay and its use to monitor paralog-specific small ubiquitin-like modifier processing.
    Martin SF; Hattersley N; Samuel ID; Hay RT; Tatham MH
    Anal Biochem; 2007 Apr; 363(1):83-90. PubMed ID: 17288980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fluorescence resonance energy transfer-based assay to study SUMO modification in solution.
    Bossis G; Chmielarska K; Gärtner U; Pichler A; Stieger E; Melchior F
    Methods Enzymol; 2005; 398():20-32. PubMed ID: 16275316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
    Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
    J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
    Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
    Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation.
    Owerbach D; McKay EM; Yeh ET; Gabbay KH; Bohren KM
    Biochem Biophys Res Commun; 2005 Nov; 337(2):517-20. PubMed ID: 16198310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a high-throughput screening assay for inhibitors of small ubiquitin-like modifier proteases.
    Yang W; Wang L; Paschen W
    J Biomol Screen; 2013 Jun; 18(5):621-8. PubMed ID: 23470489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms in SUMO conjugation.
    Varejão N; Lascorz J; Li Y; Reverter D
    Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Förster resonance energy transfer analysis for kinetic determinations of SUMO-specific protease.
    Liu Y; Song Y; Madahar V; Liao J
    Anal Biochem; 2012 Mar; 422(1):14-21. PubMed ID: 22244808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy.
    Matic I; van Hagen M; Schimmel J; Macek B; Ogg SC; Tatham MH; Hay RT; Lamond AI; Mann M; Vertegaal ACO
    Mol Cell Proteomics; 2008 Jan; 7(1):132-44. PubMed ID: 17938407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.
    Gareau JR; Lima CD
    Nat Rev Mol Cell Biol; 2010 Dec; 11(12):861-71. PubMed ID: 21102611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved and buried edge-to-face aromatic interaction in small ubiquitin-like modifier (SUMO) has a role in SUMO stability and function.
    Chatterjee KS; Tripathi V; Das R
    J Biol Chem; 2019 Apr; 294(17):6772-6784. PubMed ID: 30824543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of SUMO protease activity using a sensitive enzyme-based reporter assay.
    Leach CA; Tian X; Mattern MR; Nicholson B
    Methods Mol Biol; 2009; 497():269-81. PubMed ID: 19107424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
    Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
    J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and paralogue specificity of mammalian deSUMOylating enzymes.
    Kolli N; Mikolajczyk J; Drag M; Mukhopadhyay D; Moffatt N; Dasso M; Salvesen G; Wilkinson KD
    Biochem J; 2010 Sep; 430(2):335-44. PubMed ID: 20590526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.
    Impens F; Radoshevich L; Cossart P; Ribet D
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12432-7. PubMed ID: 25114211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
    Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
    Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.